Updates are available Correction dated 2024-03-25
Click to view Correction: https://doi.org/10.1186/s12885-024-12150-8
-
Authors
Huang, Weiwei
Wang, Chenxi
Shen, Yangkun
Chen, Qi
Huang, Zhijian
Liu, Jian
Lin, Xiaoyan
Wang, Lili
Wu, Fan
Chen, Xinhua
Li, Nani
Hong, Yi
Chen, Mulan
Li, Jieyu
Huang, Chuanzhong
-
Funding
Funding for this research was provided by:
Wu JiePing Medical Foundation Special Fund for Clinical Research (320.6750.2021-14-6)
Natural Science Foundation of Fujian Province (2023J011275, 2021J01440)
Fujian Provincial Clinlical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012)
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 22 December 2023
First Online: 5 January 2024
Change Date: 25 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12885-024-12150-8
Declarations
:
: All the patients were informed about the purposes of the study. All investigations conformed to the principles outlined in the Declaration of Helsinki (as revised in 2013) and were performed with permission by the responsible Fujian Provincial Tumor Ethics Committee and Chinese Ethics Committee of Registering Clinical Trials. All participants in this study have provided informed written consent.
: Not Applicable.
: The authors declare no competing interests.
